Gap Cancer 14: What biodosimetry methods are required for exploration missions and how can biomarker approaches be used for outcome prediction and surveillance?
This Gap was merged into the following Gap:
Cancer-401: Identify biomarkers for estimating individual susceptibility, risk assessment, and health monitoring.

Merge Rationale
No rationale available.